Press release
Investigation announced for Investors in shares of Absci Corporation (NASDAQ: ABSI)
An investigation for investors in Absci Corporation (NASDAQ: ABSI) shares over potential securities laws violations by Absci Corp.
Investors who purchased shares of Absci Corporation (NASDAQ: ABSI), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Absci Corporation regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
Vancouver, WA based Absci Corporation, an AI-powered synthetic biology company, offers biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Absci Corporation reported that its annual Total Revenue rose from $2.06 million in 2019 to $4.78 million in 2020, and that its Net Loss increased from $6.58 million in 2019 to $14.35 million in 2020.
On or around July 22, 2021, Absci Corporation (NASDAQ: ABSI) conducted its initial public offering ("IPO"), offering 12.5 million shares of common stock priced at $16.00 per share.
Then, on September 7, 2021, Absci Corporation (NASDAQ: ABSI) reported its financial and operating results for the second quarter of 2021. Among other items, Absci Corporation (NASDAQ: ABSI) reported earnings per share and revenue that both fell significantly short of consensus estimates.
Shares of Absci Corporation (NASDAQ: ABSI) declined to as low as $13.68 per share on September 9, 2021.
Those who purchased shares of Absci Corporation (NASDAQ: ABSI) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Investors in shares of Absci Corporation (NASDAQ: ABSI) here
News-ID: 2393161 • Views: …
More Releases from Shareholders Foundation
ALERT: Lawsuit filed for Investors who SOLD shares of Sina Corporation (formerly …
An investor, who sold shares of Sina Corporation (formerly NASDAQ: SINA) in the merger between Seina Corporation and TuSimple Holdings, Inc, filed a lawsuit over alleged violations of Federal Securities Laws by Sina Corporation (formerly NASDAQ: SINA in connection with certain allegedly false and misleading statements made.
If you sold a significant amount of shares of Sina Corporation (formerly NASDAQ: SINA) between October 13, 2020 and March 22, 2021, you have…
Lawsuit Alert: Investors who lost money with shares of Fluor Corporation (NYSE: …
An investor, who purchased shares of Fluor Corporation (NYSE: FLR), filed a lawsuit alleged violations of Federal Securities Laws by Fluor Corporation in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Fluor Corporation (NYSE: FLR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 14, 2025. NYSE: FLR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779…
Investigation announced for Long-Term Investors in shares of Sable Offshore Corp …
An investigation was announced for long-term investors in shares of Sable Offshore Corp. (NYSE: SOC) concerning potential breaches of fiduciary duties by certain directors of Sable Offshore Corp.
Investors who are current long term investors in Sable Offshore Corp. (NYSE: SOC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in…
Lawsuit filed for Investors who lost money with shares of Lantheus Holdings, Inc …
An investor, who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH), filed a lawsuit over alleged violations of Federal Securities Laws by Lantheus Holdings, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) have certain options and for certain investors are short and strict deadlines running. Deadline: November 10, 2025. NASDAQ: LNTH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
More Releases for Absci
Antibody Discovery Market Size Report 2025: Current Landscape, Emerging Trends, …
DelveInsight's Antibody Discovery Market Insights Report 2032 provides the current and forecast market analysis, individual leading Antibody Discovery Companies market shares, challenges, Antibody Discovery Market Drivers, barriers, trends, and key market Antibody Discovery companies in the market.
To read more about the latest highlights related to the Antibody Discovery Market, get a snapshot of the key highlights entailed in the Market Report @ Antibody Discovery Market Size- https://www.delveinsight.com/sample-request/antibody-discovery-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from…
Animal Health Market to Surge with AI Innovation: Revenue Expected to Reach US$ …
The global animal health market size was valued at USD 63.3 billion in 2023 and is poised to grow from USD 67.92 billion in 2024 to USD 119.34 billion by 2032, growing at a CAGR of 7.3% in the forecast period (2025-2032). Additional market analysis projects the sector at USD 62.89 billion in 2024 with projected growth at a CAGR of 10.46% from 2025 to 2030.
AI integration will remain a…
AI in Drug Discovery Market to Soar, Reaching Nearly USD 1.95 Bn by 2030
✦ AI in Drug Discovery Market Set to Surge with 29.6% CAGR, Reaching $1.95 Billion by 2030
The global Artificial Intelligence (AI) in Drug Discovery market is experiencing significant growth, with projections indicating a compound annual growth rate (CAGR) of 29.6% from 2024 to 2030. The market, valued at USD 0.15 billion in 2023, is expected to reach nearly USD 1.95 billion by 2030.
Curious to peek inside? Grab your sample copy…
Generative AI in Drug Discovery Market Size to Reach USD 1,637.9 Million in 2032
The Generative AI in Drug Discovery market, valued at USD 216.7 million in 2024, is expected to register robust CAGR of 28.7%.
Request free copy of this report: https://navistratanalytics.com/report-store/request-free-sample/
January 20, 2025 - Demand for cost effective drug discovery is the key factor driving market revenue growth. AI in drug discovery comprises creating new content, such as molecules, compounds, or medication candidates, based by predefined criteria. One of the obstacles of…
Virtual Drug Screening System Market to See Huge Demand by 2029: Huawei, Fastone …
Latest Study on Industrial Growth of Global Virtual Drug Screening System Market 2023-2029. A detailed study accumulated to offer the Latest insights about acute features of the Virtual Drug Screening System market. The report contains different market predictions related to revenue size, production, CAGR, Consumption, gross margin, price, and other substantial factors. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study…
Biologics Drug Discovery and Development Market 2023 to 2029: Potential Growth, …
The Biologics Drug Discovery and Development market research report is proficient and top to bottom research by specialists on the current state of the industry. This statistical surveying report gives the most up to date industry information and industry future patterns, enabling you to distinguish the items and end clients driving income development and benefit. It centres around the real drivers and restrictions for the key players and present challenge…
